QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS5-Region Domestic Shipping
What is AOD-9604?
AOD-9604 (Modified HGH Fragment 177-191 (Tyr-hGH₁₇₇₋₁₉₁)) is a 17-amino acid modified GH C-terminal fragment. Modified HGH C-terminal fragment (Tyr + residues 177-191) activating lipolysis via beta-3 adrenergic receptor pathway in adipose tissue — without GH receptor binding. No IGF-1 stimulation, no anti-insulin effects, no systemic GH anabolic activity. Adipose-selective fat metabolism. Phase 2b human trial data available (obesity).
Research Applications
Adipose-Selective Lipolysis
Beta-3 adrenergic receptor activation — fat breakdown without GHR
No IGF-1 Stimulation
Clean fat metabolism model — no IGF-1, no GHR anabolic confounds
vs HGH Fragment 176-191
Tyr modification: stability, bioavailability and potency differences
Body Composition
Adipose tissue reduction research without systemic GH effects
Beta-3 AR Biology
Receptor activation, cAMP, HSL phosphorylation, fatty acid release
Quick Specs
| Form | Lyophilized powder |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | 221231-10-3 |
| Molecular Formula | C₇₈H₁₂₃N₂₃O₂₃S₂ |
| Peptide Type | Synthetic Peptide / HGH Fragment (176–191 Analog) |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house Fmoc SPPS — Qingdao, China |
| Storage | -20°C sealed | 2–8°C reconstituted (2–4 weeks) |
| Shelf Life | 24 months unopened |
